SG139546A1 - Diagnostic test - Google Patents

Diagnostic test

Info

Publication number
SG139546A1
SG139546A1 SG200404253-7A SG2004042537A SG139546A1 SG 139546 A1 SG139546 A1 SG 139546A1 SG 2004042537 A SG2004042537 A SG 2004042537A SG 139546 A1 SG139546 A1 SG 139546A1
Authority
SG
Singapore
Prior art keywords
equivalent
present
dengue virus
diagnostic test
animal
Prior art date
Application number
SG200404253-7A
Inventor
Bijon Kumarsil
Chenny Li Shi Cheng
Original Assignee
Nat Environment Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Environment Agency filed Critical Nat Environment Agency
Priority to SG200404253-7A priority Critical patent/SG139546A1/en
Publication of SG139546A1 publication Critical patent/SG139546A1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

DIAGNOSTIC TEST The present invention relates generally to a technique of detecting exposure of human and or animal to a dengue virus or equivalent thereof. More particularly, the present invention relates to an analysis of a biological sample taken from an animal or human in order to determine if the subject had been exposed to a dengue virus or equivalent thereof. The present invention further provides medical diagnostic kits for the detection of dengue virus infection or equivalent thereof. (No Figure is to accompany the publication of the Abstract)
SG200404253-7A 2004-07-22 2004-07-22 Diagnostic test SG139546A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG200404253-7A SG139546A1 (en) 2004-07-22 2004-07-22 Diagnostic test

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200404253-7A SG139546A1 (en) 2004-07-22 2004-07-22 Diagnostic test

Publications (1)

Publication Number Publication Date
SG139546A1 true SG139546A1 (en) 2008-02-29

Family

ID=39110964

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200404253-7A SG139546A1 (en) 2004-07-22 2004-07-22 Diagnostic test

Country Status (1)

Country Link
SG (1) SG139546A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824506A (en) * 1994-08-15 1998-10-20 Genelabs Diagnostics Pte. Ltd. Dengue virus peptides and methods
FR2767324A1 (en) * 1997-08-14 1999-02-19 Pasteur Institut Diagnostic kit for detecting antibodies to dengue virus serotypes
FR2794864A1 (en) * 1999-06-09 2000-12-15 Pasteur Institut Early detection of flavivirus infection, especially dengue fever, comprises detecting non-structural glycoprotein (NS1) in a sandwich assay using antibodies specific for the hexameric protein form

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824506A (en) * 1994-08-15 1998-10-20 Genelabs Diagnostics Pte. Ltd. Dengue virus peptides and methods
FR2767324A1 (en) * 1997-08-14 1999-02-19 Pasteur Institut Diagnostic kit for detecting antibodies to dengue virus serotypes
FR2794864A1 (en) * 1999-06-09 2000-12-15 Pasteur Institut Early detection of flavivirus infection, especially dengue fever, comprises detecting non-structural glycoprotein (NS1) in a sandwich assay using antibodies specific for the hexameric protein form

Similar Documents

Publication Publication Date Title
WO2006073682A3 (en) Diagnostic test
DE60207979D1 (en) Method and device for determining tissue specificity of free DNA in body fluids
WO2005034008A3 (en) A method of anonymous medical testing and providing the patient with the test results
ATE514948T1 (en) IN VITRO METHOD FOR DIAGNOSING NEURODEGENERATIVE DISEASES
WO2004069174A3 (en) Monitoring and treatment of amyotrophic lateral sclerosis
ATE461449T1 (en) METHOD FOR DETECTING MEDICALLY RELEVANT CONDITIONS IN DISSOLVED LBC SAMPLES
BR0318312A (en) Viral infection foot and mouth disease diagnostic method and Viral infection foot and mouth disease diagnostic kit
ATE423217T1 (en) ASSAY FOR MONITORING CANCER PATIENTS BASED ON LEVELS OF ANALYTE COMPONENTS OF THE PLASMINOGEN ACTIVATOR SYSTEM IN SAMPLES OF BODY FLUID
WO2005012553A3 (en) Optical in vivo probe of analyte concentration within the sterile matrix under the human nail
MX342791B (en) Elisa for vegf.
EA200801946A1 (en) AUTOMATED SAMPLE SELECTION AND THEIR ANALYSIS USING A PERSONAL TEST-ANALYZER
BRPI0506752A (en) system or method for assessing the peripheral blood circulation of an individual
DK1077634T3 (en) Monitoring of physiological analytes
WO2006119292A3 (en) Methods for detection of biological substances
MX340547B (en) Diagnostic test kits.
DE60327354D1 (en) DIAGNOSTIC ASSAY FOR DETERMINING A CELL-MEDIATED IMMUNE RESPONSE
CN107003298B (en) Chemical analysis of urine and fecal vapors
Marlina et al. Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors
CY1112423T1 (en) ANTI-USE MICROPROCESSOR'S ANALYTICAL DEVICE
US20210321904A1 (en) Systems and methods for detecting alcohol, acetone, and carbon monoxide in breath
WO2005081783A3 (en) Method for determination and quantification of radiation or genotoxin exposure
NO20053276L (en) Methods and aids for the detection of mycoplasma.
SG139546A1 (en) Diagnostic test
NZ512768A (en) Diagnostic test to detect IV cytosolic phospholipase A2 (cPLA2)
DE60229223D1 (en) SCREENING PROCEDURE FOR THE PRÄDIABETIS CONDITION AND SCREENING REAGENT